Special Issue "Antiepileptic Drugs"

Quicklinks

A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: closed (30 April 2010)

Special Issue Editor

Guest Editor
Prof. Dr. Sandra L. Helmers
Department of Neurology/Epilepsy, The Emory Clinic, 1365-A Clifton Road, NE, Suite A3400, Atlanta, GA 30322, USA
E-Mail: shelmer@emory.edu
Interests: treatment of pediatric and adult epilepsy; anticonvulsants in the treatment of epilepsy; quality indicators in epilepsy care; economic analysis of epilepsy treatments

Special Issue Information

Dear Colleagues,

This special issue will address the pharmacologic treatment of epilepy and seizures. We will explore current understandings of mechanism of actions of anticonvulsants, efficacy and side effect profiles of currently available anticonvulsants, and look at the anticonvulsant "pipeline".

Prof. Dr. Sandra L. Helmers
Guest Editor

Keywords

  • anticonvulsant medications
  • mechanism of action
  • epilepsy
  • seizures
  • anticonvulsant pharmacology
  • drug interactions
  • anticonvulsant side effects
  • anticonvulsant efficacy
  • economic analysis

Published Papers (7 papers)

Download All Papers
Sort by:
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-7
p. 3629-3632
by  and
Pharmaceuticals 2010, 3(12), 3629-3632; doi:10.3390/ph3123629
Received: 9 November 2010; Accepted: 16 December 2010 / Published: 17 December 2010
Show/Hide Abstract | Cited by 1 | PDF Full-text (49 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antiepileptic Drugs)
abstract graphic
p. 2956-2969
by
Pharmaceuticals 2010, 3(9), 2956-2969; doi:10.3390/ph3092956
Received: 29 July 2010; in revised form: 12 August 2010 / Accepted: 2 September 2010 / Published: 6 September 2010
Show/Hide Abstract | Cited by 5 | PDF Full-text (128 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antiepileptic Drugs)
p. 2709-2732
by ,  and
Pharmaceuticals 2010, 3(8), 2709-2732; doi:10.3390/ph3082709
Received: 31 May 2010; in revised form: 10 August 2010 / Accepted: 17 August 2010 / Published: 20 August 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (224 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antiepileptic Drugs)
p. 2362-2379
by  and
Pharmaceuticals 2010, 3(8), 2362-2379; doi:10.3390/ph3082362
Received: 30 June 2010; in revised form: 21 July 2010 / Accepted: 22 July 2010 / Published: 26 July 2010
Show/Hide Abstract | Cited by 2 | PDF Full-text (154 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antiepileptic Drugs)
p. 2090-2110
by
Pharmaceuticals 2010, 3(7), 2090-2110; doi:10.3390/ph3072090
Received: 10 June 2010; in revised form: 28 June 2010 / Accepted: 2 July 2010 / Published: 5 July 2010
Show/Hide Abstract | Cited by 4 | PDF Full-text (159 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antiepileptic Drugs)
p. 1909-1935
by
Pharmaceuticals 2010, 3(6), 1909-1935; doi:10.3390/ph3061909
Received: 26 April 2010; in revised form: 11 May 2010 / Accepted: 9 June 2010 / Published: 11 June 2010
Show/Hide Abstract | Cited by 7 | PDF Full-text (293 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antiepileptic Drugs)
p. 1426-1445
by  and
Pharmaceuticals 2010, 3(5), 1426-1445; doi:10.3390/ph3051426
Received: 22 April 2010; Accepted: 11 May 2010 / Published: 12 May 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (94 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antiepileptic Drugs)
Select/unselect all
Displaying article 1-7
Select articles Export citation of selected articles as:

Last update: 4 March 2014

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert